Recruiting
Phase 2

Augmented-Dose NRT

Sponsor:

Medical University of South Carolina

Code:

NCT07754578

Conditions

Dual Use of Cigarettes and E-cigarettes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Text- and web-based support

Nicotine Replacement Therapy (NRT, nicotine patch)

Nicotine Replacement Therapy (NRT, nicotine patch)

Nicotine replacement therapy lozenge

Nicotine replacement therapy lozenge

Study Details

Brief summary:

This randomized clinical trial evaluates the effectiveness of augmented-dose combination nicotine replacement therapy (NRT) versus standard-dose NRT and no-NRT control for cessation of dual combustible cigarette (CC) and electronic cigarette (EC) use. Adults who currently engage in dual use and are motivated to quit both products will be assigned to one of three 12-week interventions: (1) no pharmacotherapy (behavioral support only), (2) standard-dose NRT (21 mg nicotine patch + 4 mg lozenges, 5-20/day), or (3) augmented-dose NRT (21 mg + 14 mg patches + 4 mg lozenges, 5-30/day). All groups receive evidence-based behavioral support through the EX Program. Primary outcomes include biochemically confirmed dual abstinence and CC-only abstinence at 12 and 24 weeks. A subset of participants will provide blood and saliva samples to assess DNA damage biomarkers associated with tobacco use and cessation.

Conditions

Dual Use of Cigarettes and E-cigarettes

Study ID

NCT07754578

Start date

Nov 17, 2026

Status verified date

Aug, 2026

Completion date

Jul 10, 2031

Anticipated

Primary completion date

Apr 10, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • age 18+;
  • report nicotine-containing e-cigarette use 5+ times per day, >5 days per week, for > 6 months;
  • smoking >1 cigarette per day, >5 days per week, for >6 months;
  • interest in quitting cigarettes and e-cigarettes within the next month (>6 on 10-point scale);
  • willing to try nicotine replacement therapy;
  • access to text/internet/email.

Exclusion Criteria:

  • report use of other tobacco or nicotine products (i.e., pouches, smokeless tobacco, hookah) >1 time per week in the past 3 months;
  • have medical contraindications for nicotine replacement therapy use (patch and lozenge; e.g., recent myocardial infarction, arrhythmias, angina, vascular disease, or medical conditions in which consumption of phenylalanine is contraindicated such as PKU);
  • report current use of smoking cessation medications (varenicline, bupropion, other nicotine replacement therapies);
  • endorse symptoms of Cannabis Use Disorder (using the CUDIT assessment);
  • unable to consent (e.g., cognitive deficit, non-English speaking);
  • live outside the US.

Study Design

Enrollment

321 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

active comparator: Behavioral Support

Participants will receive behavioral support only.

experimental: Standard dose NRT

Participants will receive a standard dose of nicotine replacement therapy (NRT).

experimental: High dose NRT

Participants will receive a higher dose of NRT than what is typically used.

Interventions

Text- and web-based support

Participants will enroll in the Ex Program for support in quitting smoking and vaping.

Nicotine Replacement Therapy (NRT, nicotine patch)

21mg patch

Nicotine Replacement Therapy (NRT, nicotine patch)

21mg + 14mg patch

Nicotine replacement therapy lozenge

4mg; 5-20/day

Nicotine replacement therapy lozenge

4mg; 5-30/day

Primary outcome measure

  • Dual use abstinence [ Time Frame: Week 12, Week 24 ]
  • Cigarette abstinence [ Time Frame: Weeks 12, Week 24 ]

Central Contacts and Locations

Central contacts

Rachel Program Coordinator

(843)737-1516chrisrac@musc.edu

Talia Program Assistant

843-259-8111ogretmet@musc.edu

Locations

Medical University of South Carolina

Recruiting

Charleston, South Carolina, United States, 29425

More Information

Sponsor

Medical University of South Carolina

Last update posted

Nov 18, 2026

Last verified

Aug, 2026

Keywords

  • tobacco
  • smoking
  • cigarette
  • e-cigarette
  • dual use

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Medical University of South Carolina on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.